United In ALS research and care.
Uniting world-leading ALS researchers, clinicians, care providers, and individuals impacted by ALS to accelerate the discovery of treatments, provide critical equipment and resources to families, and foster a deeply connected, inclusive community for all affected by the disease.
No one is ever on the ALS journey alone.
A New Chapter for ALS ONE
Dear ALS ONE Community,
Over the past decade, you have helped build something truly extraordinary.
Together, we created a model rooted in collaboration based on bringing researchers, clinicians, caregivers, corporate leaders, and families together around a shared belief that ALS progress can happen faster when we work as one. Because of you, ALS ONE has funded critical research, strengthened care partnerships across Massachusetts, and helped bring innovation into the ALS space in meaningful ways.
Over the past year, our board has been thoughtfully reflecting on how ALS ONE can have the greatest impact in the rapidly evolving ALS landscape. We kept coming back to a central question: How can we make the biggest impact now leveraging our collective strength?
With that in mind, ALS ONE will be entering into a strategic integration with The ALS Network.
Through this integration, ALS ONE will become part of the ALS Network, combining our Massachusetts-based research strength, care partnerships, and technology connections with the ALS Network’s national reach and operational scale. We believe this alignment will allow us to accelerate research funding, advance the use of technology to improve patient outcomes, and expand our impact, all while preserving our long-standing commitment to the Massachusetts institutions and partners that have been central to our work.
Members of the ALS ONE board, Mark Sullivan and myself, Scott Gosnell, will join the ALS Network Board of Directors, and Michael Braun will serve as an Advisory Trustee. This ensures that ALS ONE’s mission, priorities, and relationships remain a central focus as the organizations come together.
At its core, this decision is about staying true to the original vision my father, Kevin Gosnell, had for ALS ONE: accelerating the path to treatments while improving care today through collaboration. We are incredibly proud of what this community has built over the past decade, and we believe this next chapter allows that vision to grow in a bigger and more sustainable way.
This is not an ending. It is an evolution. One designed to build on our work together and carry it forward to help as many people impacted by ALS as possible.
Thank you for being part of this journey with us. We are deeply grateful for your partnership, your belief in this mission, and the role you have played in building ALS ONE into what it is today.
With gratitude and optimism for what comes next,
Scott Gosnell
On behalf of the ALS ONE Board of Directors
ALS ONE and the ALS Network Align to Scale ALS Research and Technology Impact Nationwide
ALS ONE will become part of the ALS Network, bringing Massachusetts research strength and corporate technology expertise to accelerate progress in ALS treatment and care.
BOSTON and LOS ANGELES, February 11, 2026 — ALS ONE and the ALS Network announce a strategic integration that will unite the strengths of both organizations to accelerate progress toward faster research and improved access to care resources through ALS ecosystem enhancements and meaningful technological advancements for people living with ALS.
Together, ALS ONE and the ALS Network share a joint mission to advance care and treatments for ALS as quickly as possible. The strategic integration will strengthen research funding capabilities, expand the use of technology to improve patient outcomes, and create new opportunities to scale impact nationally, while preserving ALS ONE’s long-standing commitment to supporting Massachusetts-based organizations and research partners.
“This moment marks a real inflection point for the ALS community,” said Sheri Strahl, MPH, MBA, president and CEO of the ALS Network. “By bringing ALS ONE and the ALS Network together, we are pairing urgency with innovation – expanding access to care, accelerating research, and using technology in smarter ways, so that people living with ALS see progress sooner and feel the impact faster.”
ALS ONE has played a critical role in funding research and supporting care initiatives in Massachusetts, and that commitment will remain a priority as it becomes a part of the ALS Network. ALS Network will continue to support key Massachusetts-based institutions and partners while expanding collaboration and funding opportunities nationwide.
“Partnering with ALS ONE over the past decade has been transformational for our work at the Healey Center for ALS,” shared Dr. Merit Cudkowicz, MD, MSC, Executive Director, Mass General Brigham Neuroscience Institute and Director, Sean M. Healey & AMG Center for ALS. “We are excited that the original mission and vision of ALS ONE will continue through its partnership with the ALS Network and the expanded opportunities it will present for our research efforts and the ALS community around the country.”
“This partnership represents a powerful opportunity to harness technology, collaboration, and shared purpose to drive the next era of progress in ALS,” shared James Berry, MD, MPH, Chief, Division of ALS and Motor Neuron Diseases, Mass General Brigham. “By building on the strong foundation created by ALS ONE and working together with the ALS Network, we have the potential to transform how we advance research, expand access, and serve the ALS community nationwide.”
“Research gives us hope for the future, but care is about today. ALS ONE has helped shine a light on the real, immediate needs of people living with ALS and their families. I’m hopeful that through this new partnership, we will collectively continue to strengthen the connection between scientific progress and the compassionate, practical support people need right now,” shared Ron Hoffman, Founder & CEO, Compassionate Care ALS (CCALS).
As part of the integration, both Mark Sullivan and Scott Gosnell, ALS ONE Board Members, will join the ALS Network Board of Directors to help ensure the mission and priorities of ALS ONE remain a central focus as the organization integrates. Michael Braun, ALS ONE Board Member, will join as an ALS Network Advisory Trustee.
“This is about scale, speed and staying true to our original mission,” shared Mark Sullivan, president and CRO of Regulated Industries at Salesforce and chairman of the ALS ONE Board of Directors. “By joining forces with the ALS Network, we can unlock greater corporate funding for research, advance technology-driven solutions leveraging the Salesforce network, and continue to collaborate with the partners that ALS ONE has long supported. Most importantly, we are aligning around a single goal, delivering progress for the ALS community faster than ever before.”
“ALS ONE was my father’s vision to create a collaboration among the best and the brightest in the ALS field in order expedite the path towards a cure for ALS while improving care now,” shared Scott Gosnell, son of ALS ONE Founder Kevin Gosnell. “We are incredibly proud of what ALS ONE accomplished over the past decade, and we know that through this integration, we will be able to continue advancing his vision and impacting the ALS community.”
The integration is expected to be completed in 2026, following a phased consolidation process over the coming months pending necessary regulatory state and federal processes and approvals.
For more information about the ALS Network, please visit: alsnetwork.org.
About ALS Network
The ALS Network partners with the ALS community to drive the global discovery of prevention strategies, treatments, and cures for ALS; provide access to quality care and connection; and promote initiatives to improve health outcomes. The ALS Network serves people with ALS and their families throughout California, Hawaii, and far beyond. For more information about ALS and the ALS Network, visit alsnetwork.org or email info@alsnetwork.org. You can find the ALS Network on social media at @yourALSnetwork.
About ALS ONE
ALS ONE is ALS non-profit that supports a collaborative partnership of the top ALS experts from leading Massachusetts institutions, including ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital, and Compassionate Care ALS (CCALS). The approach of ALS ONE is to leverage the expertise from each of the research institutions through the sharing of ideas and responsibilities to advance each of the strongest therapeutic opportunities identified forward. ALS ONE also works to improve care for persons living with ALS by creating more access to clinical trials through education as well as providing technology, equipment and support services through CCALS. For more information, visit ALSONE.org.